Antiprotozoal & Antihelminthic Drugs
Start with the big picture
A useful starting point is to connect each drug’s mechanism with its principal clinical role and safety profile. Metronidazole, for example, generates radicals that damage DNA and is used for invasive amoebiasis, giardiasis, and trichomoniasis; intestinal cysts may require a luminal agent afterward. Other sections distinguish therapies for leishmaniasis, trypanosomiasis, and Chagas disease, then turn to antihelminthics. These include benzimidazoles, ivermectin, diethylcarbamazine, and praziquantel, each associated with particular parasites and cautions. The lesson also organizes key mechanisms and uses for review, helping learners compare related agents without treating them as interchangeable.
What you'll learn
- Relate major antiprotozoal drug mechanisms to their clinical uses.
- Distinguish systemic treatment from luminal therapy in amoebiasis.
- Identify important safety concerns associated with antileishmanial and antitrypanosomal agents.
- Compare major antihelminthic groups by mechanism and parasite coverage.
- Recognize selected adverse effects and cautions across drug classes.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
